Literature DB >> 30548165

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

T E van Mens1, H R Büller1, M Nieuwdorp1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30548165     DOI： 10.1111/jth.14331

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

Review 1.  Systems biology in cardiovascular disease: a multiomics approach.

Authors:  Abhishek Joshi; Marieke Rienks; Konstantinos Theofilatos; Manuel Mayr
Journal:  Nat Rev Cardiol       Date:  2020-12-18       Impact factor: 32.419

2.  TMAO: a potential mediator of clopidogrel resistance.

Authors:  Ruisong Ma; Wenwen Fu; Jing Zhang; Xiaorong Hu; Jun Yang; Hong Jiang
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

Review 3.  Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.

Authors:  Shengjie Yang; Xinye Li; Fan Yang; Ran Zhao; Xiandu Pan; Jiaqi Liang; Li Tian; Xiaoya Li; Longtao Liu; Yanwei Xing; Min Wu
Journal:  Front Pharmacol       Date:  2019-11-19       Impact factor: 5.810

4.  TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism.

Authors:  Marina Canyelles; Melania Plaza; Noemí Rotllan; Dolors Llobet; Josep Julve; Sergi Mojal; Maribel Diaz-Ricart; José Manuel Soria; Joan Carles Escolà-Gil; Mireia Tondo; Francisco Blanco-Vaca; Joan Carles Souto
Journal:  J Clin Med       Date:  2022-03-04       Impact factor: 4.241

5.  Progression of atherosclerosis with carnitine supplementation: a randomized controlled trial in the metabolic syndrome.

Authors:  Amer M Johri; Marie-France Hétu; Daren K Heyland; Julia E Herr; Jennifer Korol; Shawna Froese; Patrick A Norman; Andrew G Day; Murray F Matangi; Erin D Michos; Stephen A LaHaye; Fraser W Saunders; J David Spence
Journal:  Nutr Metab (Lond)       Date:  2022-04-02       Impact factor: 4.169
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.